EP3160467
COMBINATION COMPRISING RIFAXIMIN AND CYCLOSPORINE FOR USE IN THE TREATMENT OF BOWEL DISEASES
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
4.5.2015EP published:
10.3.2021EP application number:
15815195.1
EPO information:
European Patent Register
Max expiry date:
3.5.2035
Title:
COMBINATION COMPRISING RIFAXIMIN AND CYCLOSPORINE FOR USE IN THE TREATMENT OF BOWEL DISEASES
Timeline
Today
4.5.2015EP application
10.3.2021EP Publication
Owner
Name:
Salix Pharmaceuticals, Inc.Address:
400 Somerset Corporate Boulevard, Bridgewater, NJ 08807, US
Inventor
Name:
GOLDEN, PamAddress:
Durham, NC 27713, US
Name:
BORTEY, EnochAddress:
Chapel Hill, NC 27517, US
Name:
FORBES, WilliamAddress:
Raleigh, NC 27614, US
Name:
PATERSON, CraigAddress:
Durham, NC 27705, US
Priority
Number:
201462019388 PDate:
30.6.2014Country:
US
Number:
201462036097 PDate:
11.8.2014Country:
US
Classification
Categories:
A61K 31/437, A61K 38/13, A61P 1/00, A61P 1/12